Does Dengue Virus Suppress RNA Interference in its Mosquito Vector?

描述（由申请人提供）：节肢动物传播的病毒（虫媒病毒）在对抗脊椎动物宿主和节肢动物载体的抗病毒防御方面面临双重挑战。在脊椎动物中，对抗病毒的前线防御是干扰素（IFN）反应，而在许多节肢动物中，它是RNA干扰（RNAi），靶向破坏与双链RNA触发器同源的信使-正义RNA。虽然虫媒病毒诱导和逃避干扰素反应的能力一直是一个深入研究的领域，但对虫媒病毒和节肢动物RNAi反应之间的相互作用知之甚少。特别重要的是要调查这种相互作用的蚊子传播的黄病毒，其中包括一些重要的新兴病原体，如登革热，黄热病和西尼罗河病毒。目前，对于利用合成的短干扰RNA（siRNA）来控制黄病毒感染和传播的RNAi的潜力存在相当大的兴奋，但是对于黄病毒抑制RNAi的能力一无所知，也没有研究RNAi在控制天然载体感染中的作用。此外，目前还没有抗病毒药物可用于治疗任何黄病毒，而作为RNAi（VSR）病毒抑制剂的蛋白质可能为药物开发提供新的靶标。许多黄病毒，特别是登革病毒，需要疫苗，并且使VSR失能的突变可能有助于候选疫苗的减毒。最后，一个基本的理解的途径，载体用于控制黄病毒，和虫媒病毒用于对付他们的机制，需要解释黄病毒的进化和载体特异性的模式。拟议的研究将调查登革热病毒和RNAi在其蚊子载体之间的相互作用的三个方面：（i）确定哪些（如果有的话）DENV蛋白作为RNAi的病毒抑制因子，（ii）测量RNAi对DENV复制各种蚊子系统的影响，以及（iii）监测RNAi对DENV基因组进化的影响。登革热病毒是一种蚊子传播的病原体，每年在全球范围内导致数百万例严重疾病，因为没有预防登革热感染的疫苗，也没有治疗登革热的抗病毒药物。一种新发现的阻断病毒感染的途径，称为RNA干扰，在开发新的抗病毒疗法方面有希望。这项拟议中的研究将调查登革热病毒是否具有抵消RNA干扰的机制。

DESCRIPTION (provided by applicant): Arthropod-borne viruses (arboviruses) face a two-fold challenge in countering the antiviral defenses of both vertebrate hosts and arthropod vectors. In vertebrates, the front-line defense against viruses is the interferon (IFN) response, whereas in many arthropods, it is RNA interference (RNAi), the targeted destruction of messenger-sense RNA with homology to a double-stranded RNA trigger. While the ability of arboviruses to induce and elude the IFN response has been an area of intense study, much less is known about the interactions between arboviruses and the arthropod RNAi response. It is particularly important to investigate this interaction in the mosquito-borne flaviviruses, which include a number of important emerging pathogens such as dengue, yellow fever and West Nile virus. Currently there is considerable excitement about the potential for harnessing RNAi using synthetic short interfering RNA's (siRNA's) to control flavivirus infection and transmission, but nothing is known about the ability of flaviviruses to inhibit RNAi, nor has the role of RNAi in control of natural vector infections been studied. Additionally, there are currently no antivirals available to treat any flavivirus, and proteins that act as viral suppressors of RNAi (VSR's) may offer novel targets for drug development. Vaccines are needed for many flaviviruses, particularly dengue virus, and mutations that disable VSR's may contribute to attenuation of vaccine candidates. Finally, a fundamental understanding of the pathways that vectors use to control flaviviruses, and the mechanisms arboviruses use to counter them, are needed to interpret patterns of flavivirus evolution and vector specificity. The proposed research will investigate three aspects of the interaction between dengue virus and RNAi in its mosquito vector by: (i) identifying which, if any, DENV proteins act as a viral suppressor of RNAi, (ii) measuring the impact of RNAi on DENV replication various mosquito systems, and (iii) monitoring the impact of RNAi on DENV genomic evolution. PUBLIC HEALTH RELEVANCE Dengue virus is a mosquito-transmitted pathogen that causes millions of cases of severe disease worldwide every year because there are no vaccines to prevent dengue infection and no antiviral medications to treat dengue disease. A newly-discovered pathway that blocks viral infection, called RNA interference, holds promise in the development of new antiviral therapies. The proposed research will investigate whether dengue virus possesses mechanisms to counteract RNA interference.